معرفی
Nikol Agadzhanian is a Postgraduate Associate in the Department of Neurology at the Yale School of Medicine. Her research focuses on cancer biology, stem cell therapy, and nanoparticle-based therapeutics. She holds a B.Sc. in Biotechnology and an M.Sc. in Molecular Biology and Biotechnology from institutions in St. Petersburg, Russia. Her work includes studies on iron oxide nanoparticles in stem cells, copper-based complexes for overcoming drug resistance in tumors, and the role of autophagy in cancer progression.
Her research interests span drug delivery systems, cell signaling pathways in malignancies, and the application of mesenchymal stem cells in targeted cancer therapies. Notable projects include investigating β-catenin protein degradation in B-cell malignancies and the therapeutic potential of nuclear NAD+ salvage pathways. She has also explored the use of heparin-coated nanoparticles as liver contrast agents.
Agadzhanian’s contributions to the field include advancements in tumor theranostics and autophagy modulation strategies. Her interdisciplinary work bridges molecular biology, nanotechnology, and clinical oncology, with a focus on translational research to address treatment-resistant cancers.
